European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

  • David Coghill (Lead / Corresponding author)
  • , Tobias Banaschewski
  • , Michel Lecendreux
  • , Cesar Soutullo
  • , Mats Johnson
  • , Alessandro Zuddas
  • , Colleen Anderson
  • , Richard Civil
  • , Nicholas Higgins
  • , Andrew Lyne
  • , Liza Squires

    Research output: Contribution to journal › Article › peer-review

    107 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder'. Together they form a unique fingerprint.

    Keyphrases

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Neuroscience

    Immunology and Microbiology